These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2581838

  • 1. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
    Yoshikawa T, Nishida K, Tanigawa M, Fukumoto K, Kondo M.
    Digestion; 1985; 31(2-3):67-76. PubMed ID: 2581838
    [Abstract] [Full Text] [Related]

  • 2. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G, Silecchia G, Zanna C, Cucchiara G, Spadaro G, Greco E, Basoli A, Speranza V.
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [Abstract] [Full Text] [Related]

  • 3. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P, Haglund C, Roberts PJ, Jalanko H.
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA, Marín J, Jover JM, Fernández R, Fradejas J, Moreno M.
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [Abstract] [Full Text] [Related]

  • 5. [Serum levels and clinical evaluation of CA 19-9 in various diseases].
    Toyama K, Noto M, Sakaguchi T, Adachi K, Mitomi H, Okada N, Ootaka H, Nakazawa H, Hara E.
    Gan No Rinsho; 1985 Mar; 31(3):293-8. PubMed ID: 2582158
    [Abstract] [Full Text] [Related]

  • 6. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
    Staab HJ, Brümmendorf T, Hornung A, Anderer FA, Kieninger G.
    Klin Wochenschr; 1985 Feb 04; 63(3):106-15. PubMed ID: 3856076
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K, Kanazawa G, Kho I, Chung Y, Umeyama K.
    Am J Gastroenterol; 1985 Aug 04; 80(8):630-6. PubMed ID: 2411125
    [Abstract] [Full Text] [Related]

  • 8. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
    Frenette PS, Thirlwell MP, Trudeau M, Thomson DM, Joseph L, Shuster JS.
    Tumour Biol; 1994 Aug 04; 15(5):247-54. PubMed ID: 7991985
    [Abstract] [Full Text] [Related]

  • 9. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R, Greten H.
    Dtsch Med Wochenschr; 1984 Dec 14; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
    Steinberg WM, Gelfand R, Anderson KK, Glenn J, Kurtzman SH, Sindelar WF, Toskes PP.
    Gastroenterology; 1986 Feb 14; 90(2):343-9. PubMed ID: 2416628
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of CA 50 and CA 19-9 tumor markers in benign and malignant diseases of the upper gastrointestinal tract].
    Heptner G, Domschke S, Schneider MU, Siegfried W, Domschke W.
    Dtsch Med Wochenschr; 1986 Mar 07; 111(10):374-8. PubMed ID: 2419074
    [Abstract] [Full Text] [Related]

  • 12. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C, Clodius T, Oldörp T, Uhlenbruck G, Diehl V.
    Med Klin (Munich); 1987 Jan 30; 82(2):45-50. PubMed ID: 3470595
    [No Abstract] [Full Text] [Related]

  • 13. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Haglund C.
    Anticancer Res; 2002 Jan 30; 22(4):2311-6. PubMed ID: 12174919
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA.
    Civardi G, Cerri L, Cavanna L, Fornari F, Di Stasi M, Binelli F.
    Tumori; 1986 Dec 31; 72(6):621-4. PubMed ID: 3468674
    [Abstract] [Full Text] [Related]

  • 15. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
    Schmiegel WH, Eberl W, Kreiker C, Kalthoff H, Bützow GH, Jessen K, Klapdor R, Soehendra N, Wargenau M, Classen M.
    Hepatogastroenterology; 1985 Jun 31; 32(3):141-5. PubMed ID: 2410346
    [Abstract] [Full Text] [Related]

  • 16. Tumour markers in pancreatic cancer.
    Haglund C, Roberts PJ, Kuusela P, Jalanko H.
    Scand J Gastroenterol Suppl; 1986 Jun 31; 126():75-8. PubMed ID: 3470921
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
    Jalanko H, Kuusela P, Roberts P, Sipponen P, Haglund CA, Mäkelä O.
    J Clin Pathol; 1984 Feb 31; 37(2):218-22. PubMed ID: 6198342
    [Abstract] [Full Text] [Related]

  • 18. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.
    Ritts RE, Del Villano BC, Go VL, Herberman RB, Klug TL, Zurawski VR.
    Int J Cancer; 1984 Mar 15; 33(3):339-45. PubMed ID: 6199316
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
    Del Favero G, Fabris C, Panucci A, Basso D, Plebani M, Baccaglini U, Leandro G, Burlina A, Naccarato R.
    Bull Cancer; 1986 Mar 15; 73(3):251-5. PubMed ID: 3530354
    [Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers.
    Andriulli A, Gindro T, Piantino P, Farini R, Cavallini G, Piazzi L, Naccarato R, Dobrilla G, Verme G, Scuro LA.
    Digestion; 1986 Mar 15; 33(1):26-33. PubMed ID: 3940235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.